title: Assessment of virally vectored autoimmunity as a biocontrol strategy for cane toads.
abstract: BACKGROUND
  The cane toad, Bufo (Chaunus) marinus, is one of the most notorious vertebrate pests introduced into Australia over the last 200 years and, so far, efforts to identify a naturally occurring B. marinus-specific pathogen for use as a biological control agent have been unsuccessful. We explored an alternative approach that entailed genetically modifying a pathogen with broad host specificity so that it no longer caused disease, but carried a gene to disrupt the cane toad life cycle in a species specific manner.
  
  
  RESULTS
  The adult beta globin gene was selected as the model gene for proof of concept of autoimmunity as a biocontrol method for cane toads. A previous report showed injection of bullfrog tadpoles with adult beta globin resulted in an alteration in the form of beta globin expressed in metamorphs as well as reduced survival. In B. marinus we established for the first time that the switch from tadpole to adult globin exists. The effect of injecting B. marinus tadpoles with purified recombinant adult globin protein was then assessed using behavioural (swim speed in tadpoles and jump length in metamorphs), developmental (time to metamorphosis, weight and length at various developmental stages, protein profile of adult globin) and genetic (adult globin mRNA levels) measures. However, we were unable to detect any differences between treated and control animals. Further, globin delivery using Bohle iridovirus, an Australian ranavirus isolate belonging to the Iridovirus family, did not reduce the survival of metamorphs or alter the form of beta globin expressed in metamorphs.
  
  
  CONCLUSIONS
  While we were able to show for the first time that the switch from tadpole to adult globin does occur in B. marinus, we were not able to induce autoimmunity and disrupt metamorphosis. The short development time of B. marinus tadpoles may preclude this approach.
authors.affiliation: Australian Animal Health Laboratories, CSIRO Livestock Industries, Geelong, Victoria, Australia. jackie.pallister@csiro.au
authors.forename: Jackie A
authors.initials: JA
authors.lastname: Pallister
authors.forename: Damien C T
authors.initials: DC
authors.lastname: Halliday
authors.forename: Anthony J
authors.initials: AJ
authors.lastname: Robinson
authors.forename: Daryl
authors.initials: D
authors.lastname: Venables
authors.forename: Rhonda D
authors.initials: RD
authors.lastname: Voysey
authors.forename: Donna G
authors.initials: DG
authors.lastname: Boyle
authors.forename: Thayalini
authors.initials: T
authors.lastname: Shanmuganathan
authors.forename: Christopher M
authors.initials: CM
authors.lastname: Hardy
authors.forename: Nicole A
authors.initials: NA
authors.lastname: Siddon
authors.forename: Alex D
authors.initials: AD
authors.lastname: Hyatt
mesh_terms: D000818:Animals; D015551:Autoimmunity; D002024:Bufo marinus / Q000821:virology*; D058507:Host Specificity / Q000276:immunology*; D054884:Host-Pathogen Interactions / Q000276:immunology; D007814:Larva / Q000276:immunology / Q000821:virology; D008018:Life Cycle Stages / Q000276:immunology*; D010572:Pest Control, Biological / Q000379:methods*; D013045:Species Specificity; D014780:Viruses / Q000235:genetics*